Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exacerbations of Severe Asthma in Patients Treated With Mepolizumab: Assessment of Biomarkers and Identification of Biologic Clusters

NCT04914078 is registered in ClinicalTrials.gov with Università degli Studi di Ferrara as lead sponsor.

NCT NCT04914078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04914078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exacerbations of Severe Asthma in Patients Treated With Mepolizumab: Assessment of Biomarkers and Identification of Biologic Clusters
Lead sponsor
Università degli Studi di Ferrara
Phase
Observational
Overall status
Unknown status
Start date
September 21, 2021
Completion date
December 1, 2023
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma